4.8 Review

The roles of ERIANIN in tumor and innate immunity and its' perspectives in immunotherapy

Related references

Note: Only part of the references are listed.
Review Chemistry, Medicinal

Natural product evodiamine-inspired medicinal chemistry: Anticancer activity, structural optimization and structure-activity relationship

Zhen Wang et al.

Summary: Natural product evodiamine (Evo) is a potential drug lead with multifunctional pharmacological properties, however, its suboptimal biological activity and poor pharmacokinetics hinder its clinical application. Medicinal chemists have successfully produced synthetic analogs to overcome these deficiencies and enhance its anticancer activities. This review focuses on the structural basis, anti-cancer activities, and mechanisms of Evo and its derivatives, providing insights into optimizing strategies for the development of novel anticancer drugs.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Plant Sciences

Ethnopharmacological use, pharmacology, toxicology, phytochemistry, and progress in Chinese crude drug processing of the lateral root of Aconitum carmichaelii Debeaux. (Fuzi): A review

Meng Wang et al.

Summary: This review analyzes the effects of Fuzi processing methods on its toxicity and efficiency. The lateral roots of aconite are the known medicinal part of Fuzi; however, the aerial parts of aconite are understudied and require further research to expand its medicinal potential. Processing and compatibility are the primary means to reduce Fuzi toxicity. Nevertheless, establishing a reasonable unified safe dose range requires further discussion.

JOURNAL OF ETHNOPHARMACOLOGY (2023)

Review Plant Sciences

Modern interpretation of the traditional application of Shihu- A comprehensive review on phytochemistry and pharmacology progress of Dendrobium officinale

Jie Yang et al.

Summary: This review provides a systematic analysis of the chemical composition and pharmacological research progress of D. officinale, including over 180 compounds isolated from the plant and summarizing modern pharmacological studies on hypoglycemia, immune regulation, antioxidant, cardiovascular regulation, and gastrointestinal protection. The findings contribute to a better understanding of the traditional and modern pharmaceutical applications of D. officinale.

JOURNAL OF ETHNOPHARMACOLOGY (2023)

Review Biochemistry & Molecular Biology

Immunotherapies in rare cancers

Sneha Vivekanandhan et al.

Summary: Cancer is a major cause of death worldwide and poses a significant burden on healthcare systems and the global economy. Rare cancers, although individually occurring at low frequencies, have a much higher combined frequency of occurrence. Immune-based therapies, such as immune checkpoint inhibitors and CAR T cell therapy, have greatly improved cancer treatment in the past decade.

MOLECULAR CANCER (2023)

Editorial Material Cell Biology

START smuggling CoQ to fight ferroptosis

Deguang Liang et al.

Summary: A study suggests that PARL-mediated STARD7 processing is responsible for the cellular distribution of CoQ from mitochondria to the plasma membrane.

NATURE CELL BIOLOGY (2023)

Review Cell Biology

Pore-forming proteins as drivers of membrane permeabilization in cell death pathways

Peter Vandenabeele et al.

Summary: Regulated cell death (RCD) relies on the activation and recruitment of pore-forming proteins (PFPs) to execute specific cell death pathways. This review discusses the structural rearrangements incurred by RCD-related PFPs and describes the mechanisms behind the conversion from an autoinhibited state to a membrane-embedded state. It also highlights the formation and maturation of membrane pores and the implications of different cell death modalities on physiological and pathophysiological processes.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

P-TEFb promotes cell survival upon p53 activation by suppressing intrinsic apoptosis pathway

Zhijia Wang et al.

Summary: Positive transcription elongation factor b (P-TEFb) is a promising target in cancer, and co-targeting it with suppressors of intrinsic apoptosis could be a viable strategy to eliminate cancer cells. By combining clinically relevant antimetabolites and MDM2 inhibitors with selective inhibitors of P-TEFb, p53-dependent death of colorectal cancer cells was induced. The targeting of P-TEFb enhanced apoptosis by anti-metabolite 5-fluorouracil, and switched the fate of cancer cells by the non-genotoxic MDM2 inhibitor Nutlin-3a from cell-cycle arrest to apoptosis.

NUCLEIC ACIDS RESEARCH (2023)

Review Oncology

The Effect of Oxidative Phosphorylation on Cancer Drug Resistance

Ziyi Zhao et al.

Summary: Drug resistance in cancer patients significantly impacts their survival and quality of life, but targeting oxidative phosphorylation (OXPHOS) can eliminate cancer stem cells and delay the acquisition of drug resistance. Recent studies have shown that OXPHOS inhibitors can improve treatment responses to anticancer therapy in specific cancers, while also playing a complex role in cancer drug resistance.

CANCERS (2023)

Article Cell Biology

Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis

Dragana Savic et al.

Summary: Unfavorable clinical outcomes in HNSCC necessitate the development of new therapeutic strategies. This study demonstrates that Erk1/2 activation in HNSCC cells increases vulnerability to ferroptosis induction. Overexpression of xCT (SLC7A11) in malignant tissues suggests its potential as a druggable target.

CELLS (2023)

Article Oncology

Invasiveness of endometrial cancer cell lines is potentiated by estradiol and blocked by a traditional medicine Guizhi Fuling at clinically relevant doses

Sidra Khan et al.

Summary: Traditional Chinese medicine Guizhi Fuling has been found to inhibit the motility and invasiveness of endometrial cancer cells, potentially providing a new treatment option for advanced and resistant cancers.

FRONTIERS IN ONCOLOGY (2023)

Review Biochemistry & Molecular Biology

Sub-lethal signals in the mitochondrial apoptosis apparatus: pernicious by-product or physiological event?

Georg Hacker et al.

Summary: Mitochondria can undergo sub-lethal permeabilization, which can efficiently repair damage and may have biological significance. Recent data suggest that sub-lethal signals in the mitochondrial apoptosis pathway can drive inflammation, indicating a potential role in immune reactions. This research explores the possibility of a true biological meaning behind the release of low amounts of mitochondrial components.

CELL DEATH AND DIFFERENTIATION (2023)

Review Pharmacology & Pharmacy

Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers

Juan Jin et al.

Summary: Renal cell carcinoma (RCC) is the most prevalent type of kidney cancer, and targeted therapy with Sunitinib has become the main treatment option due to the lack of efficacy in radiation therapy and chemotherapy. However, many patients develop resistance to Sunitinib within months of therapy. In this review, we discuss the molecular mechanisms of Sunitinib resistance, strategies to overcome it, and potential predictive biomarkers.

DRUG RESISTANCE UPDATES (2023)

Article Biology

Transferred mitochondria accumulate reactive oxygen species, promoting proliferation

Chelsea U. Kidwell et al.

Summary: Recent studies have found that mitochondrial transfer between cells can impact cellular and tissue homeostasis. While most previous research focused on the transfer of functional mitochondria to cells with damaged networks, this study reveals that dysfunctional mitochondria can also be transferred between cells with functioning networks. The transfer of dysfunctional macrophage mitochondria to cancer cells leads to an accumulation of reactive oxygen species, activating signaling pathways that promote cancer cell proliferation. These findings provide insights into how transferred mitochondria can drive sustained behavioral changes in recipient cells.

ELIFE (2023)

Article Engineering, Biomedical

Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy

Yang Lin et al.

Summary: Ferroptosis is a promising approach for cancer therapy, but its efficacy is compromised by ROS production efficiency and tumor cell antioxidant microenvironment. In this study, a nanomedicine was developed to amplify ferroptosis sensitivity by controlling redox homeostasis. The nanomedicine combines a ferroptosis inducer and an antioxidant inhibitor, and it showed enhanced therapeutic efficacy in tumor therapy.

ACTA BIOMATERIALIA (2023)

Review Biochemistry & Molecular Biology

BCL-2 protein family: attractive targets for cancer therapy

Deeksha Kaloni et al.

Summary: Acquired resistance to cell death is a key characteristic of cancer. The BCL-2 protein family members have important roles in regulating apoptotic cell death. Abnormal expression of pro-survival BCL-2 family proteins or reduction in pro-apoptotic BCL-2 family proteins, both leading to inhibition of apoptosis, are commonly observed in various types of cancer. The critical role of pro-survival and pro-apoptotic BCL-2 family proteins in apoptosis regulation makes them attractive targets for cancer treatment. This review discusses the roles of different pro-survival and pro-apoptotic members of the BCL-2 protein family in normal development and organismal function, as well as how defects in apoptosis control contribute to cancer development and therapy resistance. Lastly, the development of inhibitors targeting pro-survival BCL-2 proteins, known as BH3-mimetic drugs, as novel agents for cancer therapy is discussed.

APOPTOSIS (2023)

Review Toxicology

Molecular mechanisms behind ROS regulation in cancer: A balancing act between augmented tumorigenesis and cell apoptosis

Hardeep Singh Tuli et al.

Summary: ROS plays important roles in living organisms, with moderate levels affecting disease development and excessive levels leading to cell death. Current research is focused on using chemotherapy drugs and herbal agents to induce cancer cell death, while maintaining ROS homeostasis is crucial for cell development and survival.

ARCHIVES OF TOXICOLOGY (2023)

Review Oncology

Autophagy, molecular chaperones, and unfolded protein response as promoters of tumor recurrence

Bashar Alhasan et al.

Summary: Tumor recurrence is a complex process involving cancer cell dormancy, proteostasis mechanisms, and signaling systems that regulate cell proliferation. Dormant cancer cells, including cancer stem cells and drug-tolerant persisters, can persist in a resistant state before transitioning to proliferation. During dormancy and reawakening, various mechanisms, such as autophagy and the unfolded protein response, protect tumor cells from stressors and therapeutic insults. Proteostasis mechanisms play a critical role in interfering with regulators of tumor relapse. This review discusses the significance of these interactions in the phases of tumor recurrence.

CANCER AND METASTASIS REVIEWS (2023)

Article Oncology

Prognostic significance of natural products against multidrug tumor resistance

Pankaj Garg et al.

Summary: Cancer is a widespread and constantly evolving disease that poses a significant public health concern. Despite advancements in treatment strategies, such as surgery, radiation, and pharmaceutical therapies, there has been little improvement in cancer-related death rates. As a result, natural product-based therapeutic discoveries are being considered as an alternative approach. Primary prevention plays a crucial role in global cancer control, and this review provides an overview of the mechanisms by which bioactive ingredients in natural dietary products may contribute to the prevention and management of various malignancies.

CANCER LETTERS (2023)

Article Oncology

Saikosaponin A enhances Docetaxel efficacy by selectively inducing death of dormant prostate cancer cells through excessive autophagy

Jiling Feng et al.

Summary: Quiescent cancer cells (QCCs), also known as dormant cancer cells, can survive and resist chemotherapy and radiation therapy, leading to treatment failure and cancer recurrence. Saikosaponin A (SSA) derived from Bupleurum DC. has been found to effectively eliminate multidrug-resistant QCCs compared to proliferative cancer cells. SSA induces cell death in QCCs by exacerbating autophagy through inactivation of Akt-mTOR signaling. Inhibition of autophagy or activation of the Akt pathway can prevent SSA-induced cell death. Treatment with SSA in combination with Docetaxel can increase cell death and inhibit tumor growth, providing a potential strategy to improve treatment effectiveness and prevent cancer recurrence.

CANCER LETTERS (2023)

Review Pharmacology & Pharmacy

Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade

Kun Pang et al.

Summary: The PD-1/PD-L1 immune checkpoint plays a crucial role in tumor immune escape, but the main challenges of this therapy are low response rate and acquired resistance, thus further research is needed to improve the treatment outcome.

DRUG RESISTANCE UPDATES (2023)

Article Biochemistry & Molecular Biology

Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2

Penglei Wang et al.

Summary: In this study, Erianin was found to suppress the activation of the MAPK signaling pathway induced by BRAF V600E or RAS mutations in melanoma and colorectal cancer cells. It inhibited the activities of MEK1/2 and CRAF kinases, leading to the suppression of tumor growth. This discovery provides a promising candidate compound for the treatment of BRAF V600E or RAS mutant melanoma and colorectal cancer.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)

Review Oncology

STAT proteins in cancer: orchestration of metabolism

Yi-Jia Li et al.

Summary: Reprogrammed metabolism is a key feature of cancer, and it involves a variety of distinct cellular metabolic pathways. This review focuses on the roles of STAT proteins, particularly STAT3, STAT5, STAT6, and STAT1, in regulating the dynamic metabolism of cancer cells, immune cells, and adipocytes in the tumor microenvironment. STAT proteins have the ability to shape different metabolic processes that regulate tumor progression and therapy resistance, including transducing signals from metabolites, cytokines, growth factors, and their receptors; defining genetic programs that control metabolism in cancer and immune cells; and regulating mitochondrial activity. Targeting STAT proteins could be a potential therapeutic strategy for altering metabolic reprogramming in cancer.

NATURE REVIEWS CANCER (2023)

Review Oncology

Targeting DNA damage response pathways in cancer

Florian J. Groelly et al.

Summary: Cells have a complex network called the DNA damage response (DDR) to prevent detrimental mutations and coordinate DNA repair, cell-cycle checkpoint activation, and other cellular responses. Mutations in DDR genes are frequently found in cancer, causing genomic instability and influencing the tumor's response to DNA damage treatments. Tumors with mutated BRCA1 or BRCA2 are particularly susceptible to chemotherapeutic inhibitors of PARP, which has become a targeted therapy for cancer.

NATURE REVIEWS CANCER (2023)

Review Cell Biology

Telomere dysfunction in ageing and age-related diseases

Francesca Rossiello et al.

Summary: The article reviews the impact of telomere shortening and dysfunction on aging and a variety of age-related diseases in humans. Accumulation of senescent cells in aging organisms is believed to contribute to bodily dysfunction. Telomere shortening and damage are known causes of cellular senescence and aging. The authors argue that telomeric dysfunction plays a broad role in human pathologies associated with normal aging.

NATURE CELL BIOLOGY (2022)

Review Plant Sciences

Research Advances in Multi-Omics on the Traditional Chinese Herb Dendrobium officinale

Yue Wang et al.

Summary: This review summarizes the latest research advances in Dendrobium officinale, including multiple omics studies and the biosynthetic pathway and regulation mechanisms of bioactive compounds. The limitations of current research are discussed, and prospective topics in need of further study on D. officinale are proposed.

FRONTIERS IN PLANT SCIENCE (2022)

Article Biochemistry & Molecular Biology

Inhibition of DUSP6 Activates Autophagy and Rescues the Retinal Pigment Epithelium in Sodium Iodate-Induced Retinal Degeneration Models In Vivo and In Vitro

Hao-Yu Tsai et al.

Summary: Inhibition of DUSP6 activity promotes autophagy flux and restores retinal damage caused by oxidative stress. DUSP6 inhibitor shows potential therapeutic effects in treating retinal degeneration.

BIOMEDICINES (2022)

Article Chemistry, Medicinal

Erianin suppresses proliferation and migration of cancer cells in a pyruvate carboxylase-dependent manner

Jing Hong et al.

Summary: The target protein of erianin in human cells was identified as pyruvate carboxylase, and the anti-tumor signaling pathway regulated by erianin was explored in various cell lines. Erianin specifically inhibits the activity of pyruvate carboxylase and selectively inhibits the activity of pyruvate carboxylase. Erianin can also regulate the pyruvate carboxylase-mediated Wnt/ β-Catenin pathway.

FITOTERAPIA (2022)

Review Oncology

Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research

Xuhui Tong et al.

Summary: This article discusses the molecular processes and effects of necroptosis, pyroptosis, ferroptosis, and cuproptosis on tumor cell proliferation and cancer metastasis, as well as the complex effects of these novel types of tumor cell death on the tumor microenvironment and regulated death of other cells in the microenvironment.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Review Biochemistry & Molecular Biology

Beyond target cell death - Granzyme serine proteases in health and disease

Simone Nussing et al.

Summary: Granzymes are small serine proteases stored in and released from cytotoxic T lymphocytes and natural killer cells. They activate signaling pathways and inactivate viral proteins. Besides their pro-apoptotic functions, they also play a role in other biological processes, including immunoregulation.

MOLECULAR ASPECTS OF MEDICINE (2022)

Review Biochemistry & Molecular Biology

Restoring TRAILR2/DR5-Mediated Activation of Apoptosis upon Endoplasmic Reticulum Stress as a Therapeutic Strategy in Cancer

Rocio Mora-Molina et al.

Summary: This review article discusses the molecular mechanisms regulating cell fate decisions in tumor cells undergoing ER stress, with a focus on the role of TRAIL-R2/DR5 in the apoptotic process and the mechanisms controlling FLIP levels.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Oncology

Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy

Yu Fujiwara et al.

Summary: Strategies to overcome immunosuppression in the tumor microenvironment, such as IDO1 inhibition, have been explored to address resistance to immune checkpoint blockade. These strategies have shown promising results in preclinical studies and early-phase clinical trials. However, some clinical trials have yielded disappointing results, dampening enthusiasm for IDO inhibitors. Additional potential targets, such as the aryl hydrocarbon receptor and tryptophan 2,3-dioxygenase, have been proposed to enhance clinical effectiveness. The expression level of IDO1 varies among tumors and patients, highlighting the importance of patient selection based on IDO1 expression levels in clinical trials.

CANCER TREATMENT REVIEWS (2022)

Article Biochemistry & Molecular Biology

Erianin-Loaded Photo-Responsive Dendrimer Mesoporous Silica Nanoparticles: Exploration of a Psoriasis Treatment Method

Huanan Yu et al.

Summary: Psoriasis is a chronic inflammatory skin disorder that can be effectively treated using a novel drug delivery system based on photo-responsive nanoparticles. This system improves the bioavailability and sustained release of the drug, providing a promising strategy for psoriasis therapy.

MOLECULES (2022)

Article Oncology

Tumor glycolysis, an essential sweet tooth of tumor cells

Sumana Paul et al.

Summary: Cancer cells undergo metabolic alterations to meet energy demands, with glycolysis playing a central role. Glycolysis is intertwined with other metabolic pathways, leading to diverse and heterogeneous cancer metabolism. Oncogenic signaling enhances glycolytic enzyme activity, promoting tumor growth and metastasis. This article discusses the interactions between tumor glycolysis and other metabolic pathways, the role and regulation of key enzymes, and the significance of lactate in tumor growth and metastasis.

SEMINARS IN CANCER BIOLOGY (2022)

Review Pharmacology & Pharmacy

Research and development of Chinese anti-COVID-19 drugs

Xiwei Ji et al.

Summary: The outbreak of COVID-19 has emphasized the importance and urgency of developing therapeutic drugs, and China has made notable progress in this area. This article summarizes the anti-COVID-19 drugs and promising drug candidates developed in China, discussing their prospects, mechanisms of action, and advantages and disadvantages. It aims to contribute to the rational use of drugs in COVID-19 treatment and the development of new drugs against SARS-CoV-2 and its variants.

ACTA PHARMACEUTICA SINICA B (2022)

Article Pharmacology & Pharmacy

Overcoming cancer chemotherapy resistance by the induction of ferroptosis

Yumin Wang et al.

DRUG RESISTANCE UPDATES (2022)

Article Ophthalmology

Erianin Controls Collagen-Mediated Retinal Angiogenesis via the RhoA/ROCK1 Signaling Pathway Induced by the alpha2/beta1 Integrin-Collagen Interaction

Xueke Li et al.

Summary: This study found that erianin can regulate collagen-mediated retinal angiogenesis by suppressing the expression of integrins and may function through the RhoA/ROCK1 signaling pathway.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2022)

Review Biochemistry & Molecular Biology

Signal pathways and precision therapy of small-cell lung cancer

Min Yuan et al.

Summary: Small-cell lung cancer (SCLC) is a subtype of lung cancer characterized by high proliferation, early metastasis, and poor prognosis. Recent studies have identified extensive chromosomal rearrangements, high mutation burden, and loss-of-function mutations in tumor suppressor genes in SCLC. There are currently six potential treatable signaling pathways in SCLC. However, their role in SCLC tumor biology and cancer growth promotion is not well understood. Further research is needed to optimize drug targets, improve drug pharmacology, and identify potential biomarkers for novel therapies in SCLC.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Review Biochemistry & Molecular Biology

Switching from Apoptosis to Pyroptosis: Gasdermin-Elicited Inflammation and Antitumor Immunity

Kohsuke Tsuchiya

Summary: Pyroptosis is a regulated form of cell death, executed by Gasdermines (GSDMs) that form pores in the plasma membrane leading to cell lysis. Pyroptotic cells release pro-inflammatory molecules, eliciting inflammation and immune responses. Recent studies have advanced our understanding of pyroptosis mechanisms and roles, which may aid in the development of cancer immunotherapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Plant Sciences

Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification

Yan Wang et al.

Summary: Dendrobium chrysotoxum Lindl, a traditional Chinese medicinal herb, has shown promising clinical effects in treating chronic gastritis and precancerous lesions of gastric cancer. This study used network pharmacology to identify active ingredients and pharmacological mechanisms of Dendrobium chrysotoxum Lindl in the prevention and treatment of PLGC. The main active ingredient Erianin was found to regulate cancer-related signaling pathways and inhibit cell viability, migration, and induce apoptosis in PLGC, suggesting its potential as a candidate for PLGC treatment methods.

JOURNAL OF ETHNOPHARMACOLOGY (2021)

Article Pharmacology & Pharmacy

Natural Product Erianin Inhibits Bladder Cancer Cell Growth by Inducing Ferroptosis via NRF2 Inactivation

Yu Xiang et al.

Summary: The natural compound erianin has shown anticancer activity in various cancers, and in this study, it was found to initiate ferroptosis and lipid peroxidation in bladder cancer cells. The induction of ferroptosis by erianin may provide a promising treatment strategy for bladder cancer.

FRONTIERS IN PHARMACOLOGY (2021)

Article Immunology

Erianin: A Direct NLRP3 Inhibitor With Remarkable Anti-Inflammatory Activity

Xinyong Zhang et al.

Summary: The study shows that Erianin inhibits NLRP3 inflammasome activation, leading to therapeutic effects on peritonitis, gouty arthritis, and type 2 diabetes in mouse models. It may serve as a potential novel therapeutic compound against NLRP3-driven diseases.

FRONTIERS IN IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway

Yonggang Xu et al.

Summary: Erianin inhibits the proliferation of TNBC cells and induces cell cycle arrest and apoptosis by suppressing the activation of the PI3K/Akt pathway.

BIOSCIENCE REPORTS (2021)

Article Cell Biology

The effect and mechanism of erianin on the reversal of oxaliplatin resistance in human colon cancer cells

Chang Su et al.

Summary: Erianin significantly inhibits the proliferation of human colon cancer oxaliplatin-resistant cells and suppresses the cell cycle of these cells in the G2/M phase, indicating its potential to regulate MDR phenotype through the inhibition of STAT3 signaling pathway and reduction of P-gp expression. This study provides a theoretical basis for the clinical application of erianin in platinum-based chemotherapy for colon cancer.

CELL BIOLOGY INTERNATIONAL (2021)

Article Plant Sciences

Erianin regulates programmed cell death ligand 1 expression and enhances cytotoxic T lymphocyte activity

Ao Yang et al.

Summary: Dendrobium chrysotoxum Lindl is a traditional Chinese medicine with various clinical applications. Erianin, a key component, has been shown to inhibit PD-L1 expression and interfere with HIF-1? synthesis through specific pathways. Additionally, erianin has demonstrated anti-proliferative effects and restored cytotoxic T lymphocytes ability, suggesting potential for improving immunotherapy against cervical cancer and other malignancies.

JOURNAL OF ETHNOPHARMACOLOGY (2021)

Article Chemistry, Medicinal

Erianin inhibits human lung cancer cell growth via PI3K/Akt/mTOR pathway in vitro and in vivo

Hui-qiong Zhang et al.

Summary: Erianin, a small-molecule compound isolated from Dendrobium chrysotoxum Lindl, demonstrates evident antitumor activity in lung cancer cells by inhibiting cell growth and inducing apoptosis and cell cycle arrest through the PI3K/Akt/mTOR pathway. Additionally, in a mouse xenograft model, Erianin shows promise as a potential treatment for lung cancer by inhibiting tumor growth and enhancing immune function.

PHYTOTHERAPY RESEARCH (2021)

Review Cell Biology

ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer

Reiko Sugiura et al.

Summary: The RAF/MEK/ERK signaling pathway regulates various cellular processes and its activation is linked to cell proliferation and cancer. Further research on the mechanisms of ERK activation is essential for developing effective cancer treatments.

CELLS (2021)

Article Oncology

Ceramide Regulates Anti-Tumor Mechanisms of Erianin in Androgen-Sensitive and Castration-Resistant Prostate Cancers

I. Gusti Md Gde Surya C. Trapika et al.

Summary: Prostate cancer is the second most prevalent malignancy worldwide, thus novel treatments are urgently needed. Research shows that erianin exhibits anti-tumor effects in both androgen-sensitive and castration-resistant prostate cancer cells through different mechanisms.

FRONTIERS IN ONCOLOGY (2021)

Article Integrative & Complementary Medicine

Erianin Induces Apoptosis and Autophagy in Oral Squamous Cell Carcinoma Cells

Yi-Tzu Chen et al.

AMERICAN JOURNAL OF CHINESE MEDICINE (2020)

Article Oncology

Ruscogenin induces ferroptosis in pancreatic cancer cells

Zhiwang Song et al.

ONCOLOGY REPORTS (2020)

Article Biotechnology & Applied Microbiology

Development of erianin-loaded dendritic mesoporous silica nanospheres with pro-apoptotic effects and enhanced topical delivery

Canlong Mo et al.

JOURNAL OF NANOBIOTECHNOLOGY (2020)

Article Chemistry, Medicinal

Enterovirus D68 Antivirals: Past, Present, and Future

Yanmei Hu et al.

ACS INFECTIOUS DISEASES (2020)

Article Chemistry, Medicinal

Dual Targeting of Cell Growth and Phagocytosis by Erianin for Human Colorectal Cancer

Yihan Sun et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2020)

Review Chemistry, Multidisciplinary

Tumor-Targeted Nanomedicine for Immunotherapy

Horacio Cabral et al.

ACCOUNTS OF CHEMICAL RESEARCH (2020)

Article Biochemistry & Molecular Biology

A unified model for the G1/S cell cycle transition

Samuel Hume et al.

NUCLEIC ACIDS RESEARCH (2020)

Article Medicine, Research & Experimental

Erianin induces cell apoptosis through ERK pathway in human nasopharyngeal carcinoma

Yen-Tze Liu et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Review Pharmacology & Pharmacy

The Function of RAS Mutation in Cancer and Advances in its Drug Research

Shijie Chen et al.

CURRENT PHARMACEUTICAL DESIGN (2019)

Article Food Science & Technology

Erianin protects against high glucose-induced oxidative injury in renal tubular epithelial cells

Mei-Fen Chen et al.

FOOD AND CHEMICAL TOXICOLOGY (2019)

Article Biochemistry & Molecular Biology

Biological and anti-vascular activity evaluation of ethoxy-erianin phosphate as a vascular disrupting agent

Wenshuang Yuan et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Review Biotechnology & Applied Microbiology

Progressive study of effects of erianin on anticancer activity

Yuying Zhang et al.

ONCOTARGETS AND THERAPY (2019)

Review Chemistry, Medicinal

Natural products as multidrug resistance modulators in cancer

Amit Kumar et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Biochemistry & Molecular Biology

Resurrection of ancestral effector caspases identifies novel networks for evolution of substrate specificity

Robert D. Grinshpon et al.

BIOCHEMICAL JOURNAL (2019)

Article Chemistry, Medicinal

Effect of ingredients from Chinese herbs on enterovirus D68 production

Xiangling Meng et al.

PHYTOTHERAPY RESEARCH (2019)

Review Plant Sciences

Genome-wide researches and applications on Dendrobium

Shi-gang Zheng et al.

PLANTA (2018)

Article Food Science & Technology

Erianin against Staphylococcus aureus Infection via Inhibiting Sortase A

Ping Ouyang et al.

TOXINS (2018)

Article Biochemistry & Molecular Biology

Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma

Weijun Ou et al.

FREE RADICAL BIOLOGY AND MEDICINE (2017)

Article Medicine, Research & Experimental

Erianin inhibits indoleamine 2, 3-dioxygenase - induced tumor angiogenesis

Chang Su et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Review Biotechnology & Applied Microbiology

Natural products as probes in pharmaceutical research

Esther K. Schmitt et al.

JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY (2016)

Review Cell Biology

Ferrootosis: Death by Lipid Peroxidation

Wan Seok Yang et al.

TRENDS IN CELL BIOLOGY (2016)

Review Cell Biology

Heat shock response and autophagy-cooperation and control

Karol Dokladny et al.

AUTOPHAGY (2015)

Article Biochemistry & Molecular Biology

Regulation of Ferroptotic Cancer Cell Death by GPX4

Wan Seok Yang et al.

Article Biochemistry & Molecular Biology

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

Scott J. Dixon et al.

Review Pharmacology & Pharmacy

Targeting the PI3K signaling pathway in cancer therapy

Chandra Bartholomeusz et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2012)

Article Biochemistry & Molecular Biology

Prostate Apoptosis Response 4 (Par-4), a Novel Substrate of Caspase-3 during Apoptosis Activation

Parvesh Chaudhry et al.

MOLECULAR AND CELLULAR BIOLOGY (2012)

Review Pharmacology & Pharmacy

p62/SQSTM1/A170: Physiology and pathology

Masaaki Komatsu et al.

PHARMACOLOGICAL RESEARCH (2012)

Article Chemistry, Medicinal

Discovery of Isoerianin Analogues as Promising Anticancer Agents

Samir Messaoudi et al.

CHEMMEDCHEM (2011)

Review Cell Biology

Clearance of apoptotic cells: implications in health and disease

Michael R. Elliott et al.

JOURNAL OF CELL BIOLOGY (2010)

Review Pathology

Apoptosis: A review of programmed cell death

Susan Elmore

TOXICOLOGIC PATHOLOGY (2007)

Review Cell Biology

Complex networks orchestrate epithelial-mesenchymal transitions

JP Thiery et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)

Review Biochemistry & Molecular Biology

Mammalian initiator apoptotic caspases

PK Ho et al.

FEBS JOURNAL (2005)

Review Cell Biology

Mdm2 in growth signaling and cancer

Y Levav-Cohen et al.

GROWTH FACTORS (2005)

Article Oncology

In vivo and in vitro evaluation of erianin, a novel anti-anglogenic agent

YQ Gong et al.

EUROPEAN JOURNAL OF CANCER (2004)

Article Cell Biology

Epithelial-mesenchymal transitions in development and pathologies

JP Thiery

CURRENT OPINION IN CELL BIOLOGY (2003)

Review Cell Biology

Autophagic cell death and its execution by lysosomal cathepsins

Y Uchiyama

ARCHIVES OF HISTOLOGY AND CYTOLOGY (2001)

Review Biochemistry & Molecular Biology

The autophagosomal-lysosomal compartment in programmed cell death

W Bursch

CELL DEATH AND DIFFERENTIATION (2001)